UNSPSC 42202302: Medical linear accelerator intensity modulated radiation therapy IMRT three dimensional units

in this classification, this commodity indicates a product that is a device used in a linear accelerator in intensity modulated radiation therapeutic procedures in a medical setting. US FDA regulates Medical linear accelerator intensity modulated radiation therapy IMRT three dimensional units under 21 CFR 892.5050 and under FDA product code MUJ. Most nations, for tariff and trade purposes, schedule these products under HS 901819.

UNSPSC 42202302 Medical linear accelerator intensity modulated radiation therapy IMRT three dimensional units is a Commodity code under which state and local governments procure sophisticated radiation oncology equipment for cancer treatment. The code encompasses medical linear accelerators (linacs) equipped with intensity modulated radiation therapy (IMRT) and three-dimensional conformal therapy capability — machines that deliver precisely shaped radiation doses to tumors while sparing surrounding healthy tissue. State and local purchasing under this code is driven primarily by hospital systems, cancer treatment centers, and integrated health networks operated or contracted by county and municipal health departments, as well as by state health authorities managing regional oncology services. These entities acquire IMRT linacs as capital equipment purchases, typically following clinical evaluation and competitive procurement processes.

The source provides no recently posted state and local contract opportunities under this code, making it impossible to characterize geographic concentration, issuing-body patterns, or representative procurement activity at this time.